Apple lobbies to buy CXMT memory as DRAM prices quadruple, per Financial Times

Apple is pushing for US approval to buy memory chips from ChangXin Memory Technologies (CXMT), and the timing matters because DRAM memory prices have reportedly quadrupled, according to the Financial Times. In the same report, Apple’s lobbying effort is described as aimed at Commerce Department officials and other members of the Trump administration.

Why this matters right now is the obvious one, and the Financial Times stakes make it sharper: CXMT is China’s largest DRAM manufacturer, and Apple wants access to its chips despite the political and regulatory friction that comes with that label. The story also notes that CXMT sits on the Pentagon’s list of companies with alleged ties to the Chinese military, which is exactly the kind of association that tends to trigger extra scrutiny when companies ask for special permissions.

This is not just a supply chain footnote. Memory chips are the unglamorous oxygen of computing. DRAM sits behind the performance and responsiveness of everything from phones to servers, and when prices move quickly, procurement decisions get forced into the fast lane. If memory prices truly quadruple, companies typically have two competing pressures. First, they want enough supply to keep products shipping on schedule. Second, they want to avoid cost shocks that can squeeze margins or force pricing decisions that are hard to reverse.

In that context, Apple’s lobbying effort described by the Financial Times reads like an attempt to reduce procurement volatility at a moment when the market is anything but stable. The source’s framing implies Apple’s request is not simply about commercial terms with CXMT. It is about whether regulators will allow the transaction in the first place, which means compliance, licensing, and national security considerations become part of the sourcing strategy.

The Pentagon connection is the crux. CXMT’s presence on a Pentagon list of companies with alleged ties to the Chinese military is the type of detail that can complicate approvals because it elevates the issue from “economic policy” to “security policy.” Even when the actual end product is civilian consumer electronics, regulators often look at upstream suppliers as part of the risk picture. For a company like Apple, that creates an unusual dynamic: the more urgent the supply need, the more likely the process becomes politicized and protracted.

There is another layer here too. The report says six people familiar with the situation were involved in the account. That kind of sourcing usually signals that the lobbying is underway and contested enough that insiders can describe it, even if the details stay partial. For executives, that matters because it suggests the outcome is not predetermined. Approvals, denials, or conditions can change procurement timelines and force reroutes, and the companies that are most dependent on specific suppliers can end up with the least flexibility.

So what does this mean for decision-makers beyond Apple? In an era where export controls and national security review increasingly intersect with everyday components, memory sourcing is becoming a strategic governance issue. Boards and C-suite teams need to think about regulatory pathways the way they think about inventory buffers. If approvals can be lobbied, then the process is not purely mechanical. It can hinge on how regulators view risk, how companies document intended use, and how quickly administrative decisions get made.

For peers in similar roles, the second-order implication is that procurement risk is no longer only about lead times and price charts. It is also about where a supplier appears in lists tied to alleged military connections, and how a company can justify exceptions or approvals under the current administration. Apple’s attempt to navigate that terrain, as described by the Financial Times, is a reminder that when the market moves fast, regulation can move slower, and the gap between those speeds can determine whether products ship on time or costs spike when markets least expect it.